J Ripoche1, C Basurko, P Fabbro-Perray, M Prudhomme. 1. Service de chirurgie et cancérologie digestive, CHU Carémeau, place Robert-Debré, 30009 Nîmes cedex 9, France. jeremie.ripoche@yahoo.fr
Abstract
INTRODUCTION: The prevalence of parastomal hernia (PSH) varies considerably in the literature. This condition impacts negatively on quality of life. Yet there is no surgical consensus concerning treatment. The aim of the study was to determine treatment and recurrence rates of PSH in a large population of ostomy patients. PATIENTS AND METHODS: This retrospective study was carried out by a self-administered questionnaire in a population drawn at random from the database of the French federation of ostomy patients (FSF). RESULTS: Seven hundred and eighty-two patients were eligible for the study. The mean duration of follow-up was 10.5 years. PSH was reported by 202 patients (25.6%) and appeared on average 18 months after creation of the stoma. In multivariate analysis, ileostomy had a lower risk of developing PSH than did colostomy; age mote than 60 years and peristomal complications at the time of stoma creation increased the risk. Only 24% of patients with PSH were free from symptoms related to the hernia. The main complaints were pain (35%), difficulties in fitting a stomal appliance with leakage (28%); 114 patients (56%) underwent operative repair. The morbidity rate of reoperation was 33%, and 57 patients (52%) had recurrence of PSH within an average of 6 months. Transposition of the stoma to another location and the use of prosthetic mesh decreased recidivism AF recurrence? CONCLUSION: PSH aggravates the inherently diminished quality of life of stoma patients. There are many proposed surgical treatments but recurrence occurs in more than half of patients. Randomized trials on the treatment of PSH are nonexistent. The use of a prosthetic mesh may reduce the risk of recurrence. The prophylactic use of prophylactic mesh at the time of initial stoma formation is a strategy worthy of consideration.
INTRODUCTION: The prevalence of parastomal hernia (PSH) varies considerably in the literature. This condition impacts negatively on quality of life. Yet there is no surgical consensus concerning treatment. The aim of the study was to determine treatment and recurrence rates of PSH in a large population of ostomy patients. PATIENTS AND METHODS: This retrospective study was carried out by a self-administered questionnaire in a population drawn at random from the database of the French federation of ostomy patients (FSF). RESULTS: Seven hundred and eighty-two patients were eligible for the study. The mean duration of follow-up was 10.5 years. PSH was reported by 202 patients (25.6%) and appeared on average 18 months after creation of the stoma. In multivariate analysis, ileostomy had a lower risk of developing PSH than did colostomy; age mote than 60 years and peristomal complications at the time of stoma creation increased the risk. Only 24% of patients with PSH were free from symptoms related to the hernia. The main complaints were pain (35%), difficulties in fitting a stomal appliance with leakage (28%); 114 patients (56%) underwent operative repair. The morbidity rate of reoperation was 33%, and 57 patients (52%) had recurrence of PSH within an average of 6 months. Transposition of the stoma to another location and the use of prosthetic mesh decreased recidivism AF recurrence? CONCLUSION: PSH aggravates the inherently diminished quality of life of stoma patients. There are many proposed surgical treatments but recurrence occurs in more than half of patients. Randomized trials on the treatment of PSH are nonexistent. The use of a prosthetic mesh may reduce the risk of recurrence. The prophylactic use of prophylactic mesh at the time of initial stoma formation is a strategy worthy of consideration.
Authors: Sunil K Narang; Nasra N Alam; Nick J Campain; Samir Pathak; John S McGrath; Ian R Daniels; Neil J Smart Journal: Hernia Date: 2016-12-26 Impact factor: 4.739
Authors: Aleksandar Resanovic; Vladimir Resanovic; Miroslav Djordjevic; Milica Resanovic; Mazen Arafeh Journal: World J Surg Date: 2017-06 Impact factor: 3.352
Authors: Timothy F Donahue; Bernard H Bochner; John P Sfakianos; Matthew Kent; Melanie Bernstein; William M Hilton; Eugene K Cha; Alyssa M Yee; Guido Dalbagni; Hebert A Vargas Journal: J Urol Date: 2013-12-30 Impact factor: 7.450
Authors: Wissam J Halabi; Mehraneh D Jafari; Joseph C Carmichael; Vinh Q Nguyen; Steven Mills; Michael Phelan; Michael J Stamos; Alessio Pigazzi Journal: Surg Endosc Date: 2013-07-09 Impact factor: 4.584